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1. Introduction 
Several investigators have reported the presence in 
serum of a lipoprotein called lipoprotein(a) (Lp(a)) 
with a density between low density lipoprotein (LDL) 
and high density lipoprotein (HDL) (i.e., 1.05% 
1 .l 10 g/ml) and with an electrophoretic mobility on 
agarose gel between (3- and pre-/3-lipoproteins (i.e., 
pre-/31-mobility [ 11). Although the lipid composition 
of Lp(a) is almost identical with that of LDL [ 1,2], 
its apolipoprotein composition differs from the apo- 
lipoprotein composition of LDL. The main apolipo- 
protein of Lp(a) consists of apolipoprotein B (apo B) 
as in LDL. In Lp(a), however, an additional specific 
Lp(a) antigen, dissociable from apo B, has been 
detected [3]. 
collected into ethylene diaminotetra-acetic acid 
disodium salt (EDTA, 1 mg/ml final cont.). Blood 
cells and platelets were separated by low speed cen- 
trifugation. Total and HDL-cholesterol was 10 and 
1 .15 mmol/l, respectively. Triglyceride concentration 
was 4 mmol/l. The patient was diagnosed as type IIB 
(Fredrickson). Plasma from apparently healthy sub- 
jects was also prepared by collecting blood into 
EDTA followed by low speed centrifugation. 
2.2. Isolation and analysis of lipopro teins 
From [4] it is concluded that Lp(a) represents an 
independent additional risk factor for myocardial 
infarction once Lp(a) in serum is 230 mg/dl. It has 
been postulated that Lp(a) is not a metabolic product 
of other apo B-containing lipoproteins (chylomicrons, 
VLDL or LDL) and thus Lp(a) should be synthesized 
as a separate lipoprotein [5]. Furthermore Lp(a) is 
not converted into other lipoproteins [6]. At present, 
the site(s) of Lp(a) synthesis and catabolism are un- 
known. Here we describe the binding, uptake and 
degradation of Lp(a) by human fibroblasts in vitro. 
We conclude from biochemical and morphological 
studies that Lp(a) binds to the same receptor site as 
does LDL. 
LDL and Lp(a) were isolated by density gradient 
ultracentrifugation according to [7] followed by 
slicing off the respective lipoprotein band. Lipid anal- 
ysis of the isolated Lp(a) fraction was done by thin- 
layer chromatography as in [Xl. This fraction was 
analysed for the presence of apo B and apo E by 
double immunodiffusion (Ouchterlony), using mono- 
specific rabbit anti-apo B and anti-apo E antiserum in 
serial dilutions. Electrophoretic mobility of LDL and 
Lp(a) was measured, after dialysis against saline, on 
agarose gel as in [9]. Protein was determined according 
to [lo]. Cholesterol was measured using the method 
in ill]. 
2.3. Fibroblast cultures 
2. Materials and methods 
Monolayers of human foreskin fibroblasts were 
cultured to confluency in 45 mm plastic Petri dishes 
with Ham’s F 10 medium containing 15% (v/v) new 
born calf serum (NBCS). At confluence, the fibro- 
blasts were preconditioned by incubation in the same 
medium containing 15% (v/v) lipoprotein-deficient 
NBCS (LPDS, d > 1.215 g/ml) for 18 h. 
2.1. Plasma samples 
Blood from a 55 year old male patient, suffering 
from angina pectoris and tendenous xanthomas was 
2.4. Binding of lipoproteins to jibroblasts 
Isolated LDL and Lp(a) were labelled with 12’1 as 
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in [ 121. The specific activity for LDL and Lp(a) varied 
from 40-140 cpm/ng protein. Free “‘1 and 10% 
(w/v) trichloroacetic acid-soluble radioactivity were 
<l% and <5%, respectively, of the total activity. How- 
ever, the trichloroacetic acid-soluble fraction of Lp(a) 
increased dramatically (up to -10%) after storage for 
1 week at 4°C in the presence of bovine serum albumin 
(2% by wt). After incubation of the LPDS precondi- 
tioned cells with ‘*‘I-labelled lipoprotein for 2 h at 
37”C, binding, internalization and degradation of 
12’1-labelled lipoproteins were measured essentially as 
in [13]. 
2.5. Morphological studies 
For immunofluorescence microscopy, monolayers 
of fibroblasts were cultured on glass coverslips. After 
preconditioning of the cells in medium supplemented 
with 15% LPDS for 24 h at 37”C, the cells were incu- 
bated for 2 h at 4°C with LDL or Lp(a) at 50 pg pro- 
tein/ml medium. After washing with an albumin con- 
taining buffer according to [ 131, the cells were stained 
with an indirect immunofluorescence technique. In 
the first immunological step a monospecific anti-apo 
B antiserum (diluted 1:20) was used [ 141. In the 
second step goat anti-rabbit IgG conjugated with 
fluoresceine (Nordic, Tilburg) was added in a dilution 
of 1:80. The cells were examined in a Leitz orthoplan. 
For immunoelectronmicroscopy the procedure was 
exactly as in [ 151. 
3. Results and discussion 
In the density gradient ultracentrifugation pattern 
of plasma from the atherosclerotic patient (section 2) 
an additional lipoprotein class with density between 
LDL and HDL was found. For further analysis this 
additional lipoprotein was isolated from the density 
gradient tube by slicing off the corresponding lipo- 
protein band to avoid contamination with other lipo- 
proteins like LDL and HDL2. In fig.1 it is shown that 
the electrophoretic mobility of this particular lipo- 
protein lies between P(LDL) and pre-fl (very low 
density lipoprotein, VLDL). Lipid analyses showed 
that the lipid component of this lipoprotein consisted 
of 76% of neutral lipid and 24% of phospholipid. The 
total lipid consisted of 55% and 15% of cholesterol- 
esters and free cholesterol, respectively. The lipid 
composition of this lipoprotein resembles the lipid 
composition of Lp(a) as described in [ 11. Double 
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Fig.1. Agarose electrophoresis of plasma and lipoprotein 
samples. Lipoprotein samples were isolated by density gradi- 
ent ultracentrifugation followed by slicing. Prior to electro- 
phoresis the lipoprotein samples were dialyzed against saline. 
immunodiffusion techniques (Ouchterlony) with 
monospecific anti-apo B and anti-apo E antiserum in 
serial dilutions showed only the presence of apo B. 
HDL, also has preQ mobility and also covers the 
density between the density of LDL and HDL. How- 
ever, since HDL, does not contain apo B, whereas in 
HDL, apo E is one of the major apolipoproteins [ 161 
we conclude that the apo B-containing and apo E-free 
pre-01 lipoprotein found in our patient is Lp(a). 
Further analysis of this Lp(a) lipoprotein by specific 
anti-Lp(a) antiserum could not be done since this anti- 
serum was not available. 
In fig.2 the binding, internalization and degrada- 
tion of ‘*’ I-labelled Lp(a) with fibroblasts is shown. 
With Lp(a) >15 pg/ml medium the binding reaches 
saturation comparable to the binding of LDL to fibro- 
blasts [ 131. Fig.3A shows that unlabelled LDL com- 
petes with ‘2SI-labelled Lp(a) for degradation by 
fibroblasts. Fig.3B shows the opposite experiment, 
i.e., Lp(a) competes with ‘*‘I-labelled LDL for degra- 
dation. The results shown in fig.3A,B present bio- 
chemical evidence that Lp(a) binds to the LDL 
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Fig.2. Interaction of Lp(a) with fibroblasts: Binding, internalization and degradation of ‘*SI-labelled Lp(a) (57 cpm/ng Lp(a) pro- 
tein) was performed as referred to in section 2. 
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Fig.3. Ability of non-radioactive LDL and Lp(a) to inhibit the degradation of respectively ‘*‘Habelled Lp(a) and ‘ZSI-labelled LDL 
by fibroblasts. (A) competition of lZSI-labelled Lp(a) (57 cpm/ng) by unlabelled LDL for degradation. Concentration of 12SI-label~ 
led Lp(a) is 15 pg/ml medium. Concentration of u&belled LDL is as indicated. Without the addition of unlabelled LDL 968 ng 
‘251-labelled Lp(a) was degraded/mg cell protein (=lOO%). (B) Competition of “SI-labelled LDL (68 cpm/ng) by unlabelled Lp(a) 
for degradation. Concentration of LZ51-labelled LDL is 22 pg/ml medium. Concentration of unlabelled Lp(a) is as indicated. With- 
out the addition of unlabelled Lp(a) 690 ng ‘zSI-labelled LDL was degraded/mg cell protein (=lOO%). 
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as (c) but LDL. 
receptor on the plasma membrane. The possibility 
that the binding of Lp(a) to the LDL-receptor is due 
to the presence of apo E containing lipoproteins (like 
HDL,) in the Lp(a) sample can be excluded because 
apo E could not be detected at all in the Lp(a) sample 
by double immunodiffusion. The binding capacity of 
the Lp(a) sample to the LDL-receptor was not due to 
a definite contamination with LDL as revealed by 
agarose electrophoresis (see fig.1). 
To obtain more evidence for the binding of Lp(a) 
to the LDGreceptor we performed morphological 
studies. Using indirect immunofluorescence micros- 
copy, both for Lp(a) and for LDL we were able to 
show the presence of apo B-immunoreactive sites on 
the cell surface (see fig.4a,b). With the technique of 
immunoelectromnicroscopy [ 151 we were able to 
visualize the binding of Lp(a) to coated pits (fig.4c) 
using anti-apo B as primary antiserum. The binding of 
Lp(a) to fibroblasts was morphologically indistinguish- 
able from the binding of LDL to fibroblasts (fig.4d). 
In case an antiserum against apo E was used [ 171 no 
binding of Lp(a) was observed. No binding of Lp(a) 
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to fibroblasts derived from patients homozygous for 
familial hypercholesterolemia could be visualized. 
Since the cells derived from homozygous hypercholes- 
terolemic patients lack LDL-receptors [ 18,191 these 
morphalogical studies confirm our biochemical results 
that Lp(a) binds to the LDL-receptor. 
No information is currently available about the 
site of the catabolism of Lp(a). In [4], individuals 
with elevated LDL levels (e.g., familial hypercholes- 
terolemic patients) generally exhibited higher Lp(a) 
levels. In [6], the kinetic parameters of Lp(a) were 
very similar to those of LDL in normal subjects. This 
paper presents evidence that Lp(a) is catabohzed via 
the specific LDL receptor pathway. Whether the effect 
of Lp(a) on the intracellular cholesterol synthesis is 
identical with that of LDL remains to be investigated. 
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